Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
4.630
-0.350 (-7.03%)
At close: May 9, 2025, 4:00 PM
4.660
+0.030 (0.65%)
After-hours: May 9, 2025, 4:21 PM EDT
Profound Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Profound Medical stock have an average target of 11.5, with a low estimate of 11 and a high estimate of 12. The average target predicts an increase of 148.38% from the current stock price of 4.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Profound Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +137.58% | Apr 23, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +159.18% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +133.26% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +94.38% | Mar 8, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +175.38% | Jan 4, 2024 |
Financial Forecast
Revenue This Year
18.28M
from 10.68M
Increased by 71.17%
Revenue Next Year
42.82M
from 18.28M
Increased by 134.25%
EPS This Year
-1.12
from -1.12
EPS Next Year
-0.87
from -1.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.0M | 50.9M | 60.6M | ||
| Avg | 18.3M | 42.8M | 58.3M | ||
| Low | 16.7M | 35.6M | 56.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.8% | 178.6% | 41.5% | ||
| Avg | 71.2% | 134.3% | 36.1% | ||
| Low | 56.0% | 94.6% | 32.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.11 | -0.62 | -1.20 | ||
| Avg | -1.12 | -0.87 | -1.15 | ||
| Low | -1.14 | -1.12 | -1.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.